Skip to main content
NewslettersWatchlist

Bluejay Diagnostics Inc(BJDX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low0.5000
Day High0.5500
Open:0.5362
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Globe Newswire
Positive Clinical Results for Bluejay’s Symphony IL-6 Test Presented at AACC 2022
Globe Newswire
Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
Globe Newswire
Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test
Globe Newswire
Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results
Globe Newswire
Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance
Globe Newswire
Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer
Globe Newswire
Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Globe Newswire
Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care
Globe Newswire
Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor
Globe Newswire
Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results
Globe Newswire
Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Profile

Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.